Currently, there are 116.36M common shares owned by the public and among those 115.77M shares have been available to trade.
The company’s stock has a 5-day price change of -16.31% and 7.07% over the past three months. CLS shares are trading 0.54% year to date (YTD), with the 12-month market performance up to 125.52% higher. It has a 12-month low price of $40.25 and touched a high of $144.27 over the same period. CLS has an average intraday trading volume of 3.79 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -24.31%, -16.23%, and 26.59% respectively.
Institutional ownership of Celestica, Inc (NYSE: CLS) shares accounts for 77.85% of the company’s 116.36M shares outstanding.
It has a market capitalization of $10.80B and a beta (3y monthly) value of 2.22. The stock’s trailing 12-month PE ratio is 24.74, while the earnings-per-share (ttm) stands at $3.75. The company has a PEG of 1.12 and a Quick Ratio of 0.91 with the debt-to-equity ratio at 0.42. Price movements for the stock have been influenced by the stock’s volatility, which stands at 10.47% over the week and 9.07% over the month.
Earnings per share for the fiscal year are expected to increase by 24.26%, and 21.18% over the next financial year. EPS should shrink at an annualized rate of 22.05% over the next five years, compared to 46.52% over the past 5-year period.
Looking at the support for the CLS, a number of firms have released research notes about the stock. JP Morgan stated their Overweight rating for the stock in a research note on February 21, 2025, with the firm’s price target at $166. Stifel coverage for the Celestica, Inc (CLS) stock in a research note released on February 04, 2025 offered a Buy rating with a price target of $140. CIBC was of a view on January 31, 2025 that the stock is Sector Outperform, while UBS gave the stock Neutral rating on November 22, 2024, issuing a price target of $95. Barclays on their part issued Overweight rating on November 05, 2024.